NCT04251221View on ClinicalTrials.gov

Measuring the Neuroimmune Response to Alcohol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

November 20, 2021

Study Completion Date

November 20, 2021

Conditions
Alcohol Drinking
Interventions
DRUG

Oral Alcohol Challenge

Subjects will drink an alcohol dose designed to achieve a BAL of 0.08

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT04251221 - Measuring the Neuroimmune Response to Alcohol | Biotech Hunter | Biotech Hunter